Trouble in Big Pharma Land: Lilly Freezes Employee Salaries
The Pharmalot blog reported today that Eli Lilly & Co one of the more progressive big pharma companies to experiment with crowdsourcing and social media to generate new R&D opportunities today announced that it most company employees and executives will not receive base pay increases this year. The company did not announce a freeze in bonuses, however.
In a sign of solidarity with the 99 %, John Lechleiter, PhD Lilly’s outspoken and sometimes controversial CEO, requested that he not receive an increase to his $1.5 million annual salary and incentives. Interesting, as Ed Silverman cogently points out in the Pharmalot post, Lechleiter’s bonus target is 140% of his base salary which put his total compensation for the upcoming year at around $16.4 million!
Last week, the company disclosed that it missed analyst’s stock price estimates and its leading product Zyprexa (antipsychotic) yielded lower than expected sales revenues because of generic competition. Zyprexa sales dropped 44 percent in the fourth-quarter to $749.6 million.
Don’t be surprised if layoffs are next. It may be time for Lilly employees to dust off those CVs and resumes.
Until next time...
While I spend most of my time as a freelancer, I sometimes will do contract work because the pay is good and the hours are reasonable. As many of you know by now, using contractors rather than hiring new employees has become the new way of controlling costs and keeping the full time headcount low. After all, paying someone an hour wage without covering insurance and other employee benefits costs can be huge savings to companies trying to maintain competitiveness and cut costs.
Those of you who manufacture products approved by the US Food and Drug Administration (FDA) are well aware of the importance of complying with Current Good Manufacturing Practices (cGMP) during FDA mandated inspections of your manufacturing facilities. Failure to comply with cGMP requirements during an inspections results in the issuance of 483s. And if you fail to adequately address the concerns of the agency outlined in 483s, it may ultimately result in issuance of warning letter to your company.
Since 2001 many major pharmaceutical companies have been restructuring their sales forces and laying off reps to reduce redundancies, improve efficiencies and cut costs. This downsizing, which likely peaked about a year ago, is mainly in response to the projected loss of sales revenue as many blockbuster drugs lose patent protection over the next three years or so. For example, products like Lipitor, Plavix and Zyprexa that currently generate more than $142 billion in sales are expected to face stiff generic competition in the very near future. .jpg)
I started BioJobBlog in 2007 primarily as a means for me to express myself about life science careers and issue and challenges confronting the biotechnology, pharmaceutical and medical devices industry. That said, I never thought that BioJobBlog would ever amount to much; it was simply a vehicle for me to rant and rave about things that were important to me! It is a daunting challenge to begin a blog with no readers and then realize that 5 years later over 2.0 million unique readers have visited to read my thoughts and ideas about a wide breadth of topics.
Cambridge, MA-based Alnylam Pharmaceuticals, one of the many companies founded on the promise of RNAi technology .jpg)
Ome Ogbru, Pharm. D, CEO and Founder of 
Asia’s largest drug maker, Takeda, 
The past several years I have been 
(2).jpg)
Earlier this week, I suggested in a .png)
Much has been written about the emerging markets in China. While there are likely thousands of business article and white papers on China’s economic expansion, I was unable to find a single source that provided me with some vital economic and social statistics to explain China’s rise as an economic power; that is until I received OnWisconsin, a quarterly publication from my alma mater the University of Wisconsin-Madison.
This past holiday season, as usual, was rife with massive layoffs and downsizing at various big pharma companies. Interestingly, in 2011, most biotechnology companies were able to weather the economic downturn and layoffs were not typical. Sadly, 2012 looks to be a more challenging year for many biotechnology company employees.
Vincent Racaniello, PhD podcaster extraordinaire and a 
In many cases, people looking for 
There are differences of opinions regarding whether or not to include certain things on a resume or curriculum vitae (CV). Some career specialists contend that it is okay to include things like an objective statement, “references upon request”, telephone numbers and hobbies on a CV whereas others do not. That said, most career experts agree that the following SHOULD NOT appear on a resume or CV 
The incomparable Mark Senak, author of the EyeonFDA blog and social media enthusiast, offers a gift this holiday season to those of you track social media use by life sciences companies. Mark has assiduously compiled a list of the life sciences companies that use social media and their platforms of choice.
I have been in the business long enough to remember when Amgen was the largest and most successful biotechnology company in the world. During most of the 90s and early 2000s, Amgen was second to none. But, a lack of innovation, questionable marketing practices and an uncreative executive management team forced the once invincible biotech Giant to recently stumble and relinquish its world class status
For many corporate employees, the annual performance review process is a bane to their existence. For those of you who may not be familiar with annual reviews, most corporate employees are required to undergo a review process that includes a synopsis of their accomplishments over the past year and new goals for the upcoming one. And, as all corporate employees understand, the quality of an annual review determines the size of the bonus that they can expect to receive and whether or not a salary increase is in order for the upcoming fiscal year. In other words, you never want to get a “less than stellar” annual review because your fiscal well-being depends on it!
The German pharmaceutical company Boehringer Ingelheim (BI) today announced that it plans on investing 70 million Euros to expand its manufacturing facility in the Zhangijiang High-Tech Park in Shanghai China. The expansion will continue through 2013 and the number of employees will increase from 240 to 400 at the new facility.jpg)
The Pharmalot blog.jpg)
Annually, the Street.Com surveys its readers to identify the year’s worst biotechnology CEO. Yes, despite large salaries, great benefits and, in most cases, outstanding employees, the executives who make the list just can't seem to do the job right.
There are a variety of reasons why the life sciences job market has been so dismal in recent years. First and foremost, there are too many applicants for too few jobs; employers are ignoring resumes/CVs that previously commanded face-to-face interviews. Second and perhaps more pernicious, is the notion among corporate executives and hiring managers that current graduates (both undergraduate and graduate students) have been catered to and are so academically untested that they bring little or no value to today’s fast-paced and demanding workplaces. While this characterization may or may not be warranted, it is a prevailing attitude that is likely hindering employment opportunities for recent life sciences graduates.(1)(1).jpg)
Last week, US unemployment dipped to 8.6%, it lowest level since 2008. Stock markets rose and everyone was buoyed by a possible economic recovery. What a difference one week can make. Today, Astra Zeneca announced that it will layoff 1,150 sales reps; a few short weeks after announcing plans to eliminate 400 jobs at is US headquarters in Wilmington, DE. The company currently employs about 61,000 workers worldwide, including 14, 000 in North America..jpg)
Despite the fact the US unemployment rate has hovered around 9.0 percent for the past several years and over 200,000 pharmaceutical employees have lost their jobs since 2001, many .jpg)
Fierce Biotech conducted its annual survey to identify top female executives in the biotechnology industry. After receiving 130 nominations, they compiled a Top 10 List for 2011. While some notable women executives may not have made it onto the 2011list, there is always next year.
While many of you are happy just because you have a job, there are those individuals (deserving or not) who are going to “bite the bullet” and ask for a raise. This makes sense because over the past few years the cost of health insurance has gone up along with college tuition, gasoline price and a variety of other things while salaries have all but stagnated. Interestingly, only 9 percent of companies have put pay freezes in place over the past 18 months; a rate this is consistent with historical standards. That is down from the nearly two-thirds of companies that imposed pay freezes in January 2010. In other words, now may be a good time to ask for a raise as companies are trying to retain high value employees who presumably were too vital to lay off when companies were downsizing over the past three years. Sadly, merit raises (when they are meted out) have precipitously dropped in recent years from an average of roughly 4-5 percent to a paltry 2 percent on average today.(1).jpg)
About two years, I posted an 
The New Jersey Governors Office 
A fascinating article entitled “
Fewer and fewer American college students are choosing to major in Science Technology, Engineering and Math (STEM). This has been an ongoing trend in the US for the past two decades. However, within the STEM majors, the life sciences are faring the best. While I believe that the US needs more life sciences majors to remain competitive with the rest of the world, there are a .jpg)
Over the past five years or so there has been a proliferation of blogs that cover the life sciences industry. While I visit some of them frequently, e.g., Pharmalot, EyeonFDA and PharmaLive,.
Blogs first began appearing on the web about 10 years ago and most experts agree that they ignited the social media revolution. While blogs are the oldest form of social media, many pharma companies are reluctant to contribute to the content of the blogosphere. This is mainly because of perceived regulatory and legal issue and consequences. Nevertheless, a few intrepid big pharma companies have taken the social media plunge and currently maintain blogs with various formats and content.
Most aspiring young scientists tell me that they love doing bench work and that they want to do it for their entire career. I am never certain whether they actually feel that way or they are simply telling me what they think I want to hear. Nevertheless, I want to share my own feelings about bench work because I think it may be instructive for jobseekers who may not be entirely certain about their chosen career paths.(1).jpg)
I just returned from the American Association of Pharmaceutical Scientists (AAPS) meeting in Washington DC where I gave three talks about biocareer development strategies. One of the talks, "Emerging Job Opportunities in the Life Sciences Industry" was reported on (see below) by a writer from Fierce Pharma. While I don't usually "too my own horn." about my achievements, I thought a Number 2 ranking in the publications daily top 10 list was certainly worth a mention. 
While LinkedIn is not considered by many to be a “true” social networking site (some consider it to be little more than a place to post an electronic resume), it is increasingly becoming the place to go to look for or find a job. Most recruiters and many hiring managers used LinkedIn to source qualified candidates for job open at their organizations. That said a well-thought-out and carefully written LinkedIn profile can make the difference between employment or not.
Over the past 10 years or so there has been an enormous amount of consolidation in the life science industry. While this activity has been very good for shareholders, it has had a devastating effort on pharmaceutical R&D says John LaMattina PhD, a chemist, .png)
Last week 
Bristol-Myers Squibb (BMS) .jpg)
Earlier this week Roche Holding AG 
Abbott Laboratories today 
Online degree programs have exploded in the past 10 years or so and are now considered to be a legitimate way to earn a second or third degree to enhance the chances of finding a job in a tough economy. Further, an article that recently appeared in the NY Times .jpeg)
Conventional wisdom suggests that failure or negative comments can be harmful or potentially damaging to the career trajectory of most people. While in many cases this may be true, sometimes they may have an opposite and unanticipated positive effect or benefit. This is certainly true for me..jpg)
Last week, US Food and Drug Administration (FDA) Commissioner 
British pharmaceutical giant AstraZeneca today announced that it would invest $200 million into a new manufacturing facility located in China Medical City in Jiangsu province in Eastern China. This is the company’s largest global investment ever in a single manufacturing facility. The new plant which will be completed by 2013 will manufacture intravenous and oral solid drugs. 
Times are tough for many in the legal profession these days. However, the demand for patent experts including attorneys and patent agents is skyrocketing. According to an 
Astra Zeneca today announced that it will eliminate 400 positions at the company’s Wilmington, DE headquarters. Most of the cuts will be in sales and marketing and the downsizing is intended “streamline portions of its commercial business to best serve patients in the US.”
From 2001 to present, roughly 300,000 pharmaceutical employees have lost their jobs. That is a massive number; second only to the job losses in the automotive and financial services industries. The main reasons for the layoffs have been a lack of return on investment on R&D activities and impending patent cliffs in 2013 for as many as 15 blockbuster drugs. 
.jpg)
Conventional wisdom has it that when economic times are tough enrollment in graduate schools tends to increase. After all, there are no jobs to be had so jobseekers go back to skill to increase their knowledge or improve their skills to be more competitive on the job market. However, according to a 
As scientists, we all subscribe to the notion that diversity is a critical component to the evolution of any species. While we this is a well known fact, the life sciences industry, like others, struggles with workforce diversity mainly in the area of research and development. For example the number of minority students—blacks and hispanics—who receive PhD degrees is miniscule as compared with their white counterparts. Graduate schools struggle to promote diversity in their programs but their efforts to date have been lackluster.
According to an
As a blogger and an occasional Twitter user (believe me I would tweet more if I didn’t have to work for a living), I have often wondered how much of an impact that the links I post have on readers and followers. While there is little doubt that the posted links persist into perpetuity, it was not clear how long people continued to click or follow the links after they were posted. That is; until now!
While getting a PhD degree in the life sciences (or most other disciplines) is no longer de rigueur, those of you out there who are courageous enough to make the attempt may benefit from an article entitled “
The US is 
Despite the fact that no new jobs were added to the US economy in August, things were pretty quiet in the pharmaceutical layoff space. From what I was able to find, it appears that 
If you received your bachelors degree in biology or a related field, there is a good chance that you are having difficulty finding a job. The lack of an advanced degree in the life sciences can hurt your chances of securing a job mainly because most life sciences jobs demand more education and experience Choosing to pursue a business degree can be a step in the right direction to advance your career.
.jpg)
I know it may appear a little odd that I am writing a post about leaving your current job given the state of the US economy and the dismal job market. However, believe it or not, there are folks out there whose skills are in demand who may have grown weary of their current job situations. With this in mind, those of you who may be considering a job change ought to ask a few questions before taking leap. 
A 
Some of you may have noticed that I have not been uploading new posts as frequently as I have in the past. I have been blogging @BioJobBlog for the past five years and quite frankly I need a little break. Traffic at the site is typically lower during the summer months so I decided to ratchet back a bit and think about the future direction of the blog. That said, I will be writing new posts from time to time but will not be back to full time blogging until after Labor Day..jpg)
A 
The tough job market and economy have caused lots of folks to consider changing careers to find gainful employment. While sometimes a career change is warranted, it may not be as easy as you think. With this in mind, there was a great article entitled
As I mentioned in numerous previous posts, health or healthcare informatics is one of the hottest and .png)
(1).jpg)
I recently wrote an article that discusses nontraditional career options for PhD life scientists and ideas about how more jobs can be created for these individuals in the the life sciences industry. The article entitled 
On episode #7 of the podcast This Week in Microbiology, Vincent, Cliff, Elio, Margaret, and Michael discuss programmed cell death in E. coli, and the daily synthesis and degradation of enzymes needed for photosynthesis and nitrogen fixation by cyanobacteria.
For the past two decade or so, government officials, business executives and many education “thought leaders” have publicly lamented the deteriorating quality of the American educational system. While K-12 educators and administrators have unduly taken much of the heat for our educational shortcomings, the real problem may lie with the quality of undergraduate education in America. To wit, while a growing percentage of American high school students are attending college, many of today’s college graduates today are noticeable deficient in communication skills and, perhaps more importantly, in their problem solving abilities. And, unfortunately, this troubling trend is beginning to takes its toll in life sciences graduate programs where a growing number of life sciences PhDs are great technicians but fail miserably as independent science investigators. This is because colleges and university administrators and faculty members are driven more by financial considerations as compared with their obligations as teachers, educators and mentors. Put simply, despite their non-profit status, many colleges and universities act like “for profit” companies where, in many cases, financial gains are more important than the products that they produce! .jpg)
.jpg)
.jpg)
Over the past several weeks, I have participated in various online conversations and discussions about the wisdom of getting a PhD degree in the life sciences. While the conversations have been wide reaching and, at times quite emotional, a common theme is beginning to emerge and I think that the time has come for me to weigh in on it. To wit, getting a PhD degree is not the best decision a person can make if he/she wants a guarantee of employment upon completion of his/her training.
The world’s largest generic pharmaceutical company Teva Pharmaceuticals Industries LTD today 
Last week’s special issue of Nature Magazine.jpg)
I am not a big fan of top ten lists but I decided to take a look at the list compiled by Cecilia Capuzzi Simon in a recent article that appeared in the April 13, 2011 New Times Education supplement. Entitled(1).jpg)
Mathew Herper, who writes at the Forbes Blog, 
By now, most BioJobBlog readers are aware that internships (paid or otherwise) have become a prerequisite at many companies to secure a full time employment. While I think internships are a great idea to jumpstart a career, not all internships are created equal or worth it. Put simply, it is up to the prospective intern to determine whether or not the advantages outweigh the disadvantages. Nevertheless, according to a report by the College Employment Research Institute three-quarters of the 10 million American students enrolled at four year colleges and universities will work as an intern before graduating. .jpg)
.jpg)
Swiss pharmaceutical giant Novartis 
While video may be losing some of its “newness" and cache in social media circles, it continues to grow and has become a mainstay of networking platforms like Facebook, Twitter, and of course YouTube! Despite its popularity in most industries, the life sciences industry continues to eschew its use. The reasons for this are not clear but it is counter intuitive given the billions of dollars the pharmaceutical and biotechnology companies annually invest in 
About a month ago, BioJobBlog in association with the JobJob Health Job Board launched the .png)
.jpg)
Despite what you may have been told, managing a career and finding new job opportunities is all about networking. Yes, I know that scientists and many other bioprofessionals loathe networking, but that is the way the game is played and if you want to win you have to play by the rules (written or otherwise).
Despite assertions to the contrary, scientists are pretty much like most other people. They eat, sleep, work, party and for the most part are social creatures. Therefore, it should come as no surprise that scientists are also susceptible to hype and succumb to research “fads.” In my former life as an academician, these fads were not so obvious and, for the most part, they unobtrusively helped to advance scientific research. However, after I abandoned academia for the private sector, these fads became blatantly obvious to me. And, for the most part, were primarily driven by potential profits rather than advancing scientific knowledge for the common good..jpg)
Sometimes job candidates do the stupidest things during job interviews. Several years ago I begged a hiring manager to give an MD a second shot at a face-to-face job interview after he botched the first one. The hiring manager reluctantly agreed to give my candidate a second chance to redeem his poor performance during the first interview. After the interview, the hiring manager told me that he wasn’t going to extend a job offer to my candidate because he was “on call” the day of the interview and he kept on excusing himself to answer his pager. This happened almost 12 years ago before the cell phone–texting explosion became annoying pervasive. 
BioCrowd (
The economic downturn has taken its toll on a number of industries including retail, manufacturing, real estate and others. Many veteran workers from these industries are unemployed and face the prospect of long term unemployment unless they develop or acquire new skills that qualify them for jobs in other areas.
Over the past few years, life sciences companies have shed over 200,000 jobs. Unfortunately, downsizing at some of these companies may not be over yet. Nevertheless, companies are always looking to recruit new talent to keep up with normal job turnover rates or to replace highly specialized employees whose skills sets are essential to successfully running the business. Because many of these former life sciences employees possessed special or arcane talents and skill sets, advertising for their replacements using conventional methods like 
Twitter, for all intents and purposes, is arguably the hottest new tool to hit the social media scene since well.....errrrrrr....Facebook (are there really any others?). That said, everyone who is anybody has jumped on the Twitter bandwagon whether or not using Twitter has any positive or negative effects for its users. Nevertheless, insightful social media analysts like Mark Senak, author of the fabulous .jpg)
A new 
While the debate rages on over the use of social media in the life sciences industry, industry experts and insiders have largely ignored the growing importance of mobile healthcare and its use by healthcare professionals and patients. Consumers and professionals are increasingly using their mobile devices for healthcare information. They are also interacting with healthcare providers and colleagues on their mobile phones. 85% of US consumers have cell phones and growing vs. only 65% of Americans which have broadband access. Further, the divide between mobile use and broadband Internet access is increasing. According to a Manhattan Research report 70% of Physicians say PDAs/Smartphones are "essential" to their practice..jpg)
What a difference six months can make in the fast moving world of the social web! At last May’s Advanced Learning Institute’s conference on “Social Media for Pharma” there was a lot of anxiety, hand wringing and concern about the future of social media in the life sciences industry. .jpg)
I have been professionally critiquing curricula vita (CV) for scientists for the past 10 years or so. While some are better than others, they all tend to suffer from the same problems and mistakes. This is mainly because scientists, unlike many other jobseekers, are rarely taught the “ins” and “outs” of resume writing. 
While I typically don’t subscribe to practice of unbridled self promotion, I could not pass on the opportunity to let my readers know that BioJobBlog made the "Top 50 Blogs About Careers in Science."
I just returned from the .jpg)
There is no question that mobile apps are de rigueur and like other mobile devices users, life science researchers are beginning to regularly use them! After all, any innovation that can make the long hours spent doing laboratory research, easier, less time-consuming and enjoyable are likely to be welcomed by most researchers.
There is no question that Facebook is the de facto social network that almost everyone uses. It has become an important source of personal information and is routinely used by professional recruiters and corporate hiring managers to identify right-fit job candidates.
“Unpleasant personality traits are almost required of young entrepreneurs trying to build something lasting. It requires tremendous arrogance to believe that their idea is better than anyone else’s. They need to be immensely selfish, putting their fragile creation ahead of everything else including important relationships. And, they have to be ruthless, tossing overboard friends who were once useful and no longer are.”
I am certain that many of you may have noticed that the size of the life sciences industry is shrinking at an unprecedented rate. Big pharma companies flush with cash, near- empty pipelines and impending patent cliffs have embarked on a buying spree that is likely to continue for next years (or at least until the economy shows clear signs of resuscitation). Pfizer’s 
While I believe that tenure ought to be abolished and the cost of a college education is way too high these days, I cannot fault non-profit post secondary educational institutions for the job that they do educating students and preparing them for life. Most do a pretty good job despite the outrageous price tag.
While a
I found an 
With unemployment high and the economy showing little sign of improvement, finding a new job has become increasingly challenging. And, not surprisingly, the types of interview questions that hiring managers are beginning to ask prospective job candidates are becoming more intricate and complex. I found interesting
In this economy, many BioJobBlog readers may find themselves in the unenviable position of having to consider changing careers to find gainful employment. While career counselors like me can offer job seekers ideas about possible alternate or non-traditional careers, actual navigating a career change can be daunting, painful and often times overwhelming. With this in mind, I came across an article on 
We are now three years into one of the worst economic downturns in the history of the US. While the job market will eventually recover, don’t expect things to be the “way they were” before the recession. In other words, the job market has undergone a paradigm shift and new job seeking rules have replaced the old ones.
Regulatory affairs professionals (RAP) are by far some of the most important employees at pharmaceutical, biotechnology and medical devices companies. Without RAPs, the requisite regulatory documents would not be filed and new drugs and devices would not be approved for marketing and sale..png)
Over 70 percent of hiring managers and HR professionals routinely use Google to find out more about prospective job candidates. While many jobseekers know this and do everything possible to expunge deleterious and compromising information from a Google search on their names, some don’t know that Facebook profiles are a routine target of all Google searches. Consequently, hiring managers may have access to some personal information (including photos) that may jeopardize a job candidate’s prospects. .jpg)
There is no question that losing a job or facing the prospect of long term unemployment can have severe emotional and psychological consequences. Sadly, I came across a
When it comes to job searching, the curriculum vitae (CV) or resume is the most important document that a jobseeker must create. Despite the importance of this document, many jobseekers, especially graduate students and postdoctoral fellows, fail to give them much thought or put much time into creating them. In today’s economy, typos, poor grammar and too much information are certain to cause most hiring managers to take a pass on you as a job candidate. However, as Caroline Potter of Yahoo HotJobs describes in her article entitled “The Biggest Resume Mistakes You Can Make” there are more critical issues that must be considered and addressed when crafting a successful CV or resume. 
Unlike PhD-trained scientists, physicians and other healthcare professionals must be licensed to practice medicine and are annually required to participate in continuing medical education courses (CME), seminars and lectures. CME training is required by medical licensing agencies to insure that healthcare practitioners are update to date with the latest clinical practices and informed about medical development within their respective fields. 
Despite assertions by its CEO that there isn’t enough scientific talent in the US, Eli Lilly announced that it will lay off a couple of thousand employees within the next 90 days. Most of the cuts will take place in Indianapolis at four different sites where the company currently employees about 13,000 workers. According to an
A recent study conducted by University of California San Diego Extension ranks careers in the health and life sciences fields at the top for recent college graduates. 
Unemployment in the US is still hovering around 10% and in some parts of Europe like Spain it is closer to 20%. In marked contrast, the unemployment rates in Australia (5.1%) Hong Kong (4.5%) and Singapore (2.2%) are much lower. With the exception of Japan, Asian economies have rebounded more quickly from the global recession than those in the West..jpg)
Although the economy is in the toilet and unemployment remains high, highly skilled and ambitious employees are usually not at risk of losing their jobs. In fact, these employees are highly sought after and frequently contacted by recruiters trying to get them to “jump ship.” In other words, there will always be jobs for these employees even though the rest of us may be unemployed. Companies clearly recognize the value of these employees and will use all available strategies to retain them. 
There is no question that interviewing is an art and that experienced job candidates may have a leg up on more junior candidates seekers when it comes to face-to-face (F2F) job interviews. That said, there is a commonly held belief among job seekers that hiring managers frequently ask silly, “bonehead” and irrelevant questions during F2F interviews. Examples of these frequently asked questions include “What are your strengths and weaknesses” and “Tell me how you overcame adversity or a difficult situation at work.” .jpg)
An article in today’s New York Times business section loudly proclaimed that the number of people using .jpg)
There are signs that the economy is improving and that unemployment levels have dropped from a high of 10.1 % to current levels which are hovering around 9.5 %. While this is good news, job cuts continue at many pharmaceutical and biotechnology companies as drug candidates fail in clinical trials and technological advances make certain employees dispensable.
I came across this excellent article written by 
The ever-increasing competition for faculty positions is forcing many graduate students and postdocs to consider careers outside of academia with a likely eye on industrial jobs. Unfortunately, many of these would be industrial scientists lack the appropriate training and qualifications for entry-level jobs at pharmaceutical and biotechnology companies. This is because most undergraduate and graduate programs do not offer training to their students in drug development, quality systems and manufacturing. The reasons for this include: 1) lack of well informed and qualified faculty members to initiate and develop specialized curricula on these topics and 2) a belief that job training is the responsibility of prospective employers, not academic researchers. Unless substantive curricular change is made to existing academic programs, the road to employment for many students will continue to be bumpy and fraught with difficulty. .gif)
BioJobBlog and Career Management Source, a producer of online applications for streamlining job searching and hiring, have teamed to create .jpg)
While the layoffs at pharma and biotech companies continue, the good news is that fewer jobs are being lost in 2010 as compared with 2009. Despite the massive loss of R&D and sales and marketing jobs, many life sciences companies are beginning to hire again. In general, job opportunities at emerging growth public biotech and venture-backed start-ups appear to be growing while those at big pharma and big biotech are stagnant or shrinking. Specifically companies are 
Mary Canady who writes the 
Now that the economy is improving and the job market is loosening up a bit, the likelihood of a face-to-face job interview is increasing. The folks over at 
John Lechleiter, PhD, chairman and CEO of Eli Lilly & Co. today told members of the Detroit Economic Club that the US is losing its competitive edge and that “evidence is mounting for an 
Despite claims of its imminent demise, it appears that social media and all of its trappings are being embraced by the masses. According to a report issued last week by CTIA, the wireless industry association, the amount of data, in text, music e-mail and other activities surpassed voice calls on mobile devices in 2009 (this explains why you cannot purchase 95 per cent of Verizon Wireless phones without a mandatory $9.99 per month data plan)..jpg)
Looking back on my career, I don’t think I would have done many things differently; except one. That is, I wouldn’t have listened as much to the advice of others who I thought knew (better than me) about what I should do with the rest of my life. Don’t get wrong, it is important to listen to what others think and the advice that they offer but—at the end of the day —the career path that you choose must be something that you like or perhaps even love to do! This sentiment was clearly and cleverly expressed in a .jpg)
.jpg)
While most successful professionals want you to believe that they “fell into” their current jobs, the truth is that they wouldn’t have made it as far as they had without thinking or divining some type of strategic career plan. The trouble is that many early career professionals buy into this assertion—and rather than chart their own career trajectories—tend to gravitate toward jobs or job titles held by these seemingly successful professionals. .jpg)
Ed Silverman who runs the Pharmalot Blog yesterday posted an .gif)
There is no doubt that it is becoming increasingly difficult for persons with PhD degrees in the life sciences to pursue traditional career paths. To that end, Anne Miller of 
A common lament from that I frequently hear from graduate students and postdoctoral scientists at career development meetings is the need for "prior industry experience" to qualify and be considered for an industrial science job. Invariably, someone asks: “How in the world am I supposed to get industrial experience if nobody is willing to hire me as an industrial scientist?” Prior to the financial meltdown, I frequently advised PhD-trained scientists seeking industrial jobs to consider positions in smaller, local biotechnology companies.
After almost a week advising students about the difference between resumes and curriculum vita (for scientists there is no difference), academic vs. an industrial curricula vitae and cover letters at .jpg)
I started writing BioJobBlog about three years ago mainly to express my personal views on a variety of topics ranging from science education and career development to happenings in the pharmaceutical and biotechnology industries. At the time, blogging was a relatively new phenomenon (especially in the life sciences space) and I had no idea whether or not anybody would really care about what I thought or had to say. 
There is a growing controversy over the rules governing whether 
In March 2009, the Smithsonian Institution Archives (SIA) created a .jpg)
According to a .jpg)
Pfizer today .jpg)
Roche .jpg)
Orphan drug manufacturer Genzyme today issued a 
Samantha Miller of the.gif)
While I was pleased that 
Until recently, there was little or no mention of business activity within the emerging Chinese life sciences industry. However, as the Chinese middle class continues to grow, the need and demand for pharmaceutical and biotechnology drugs (including vaccines and other biologics continues) to grow at a frenetic pace. Further, a growing abundance of US-trained scientists has allowed the Chinese life science industry to develop much more quickly than anticipated. Also, many major pharmaceutical companies like Merck, Roche and Novartis have invested hundreds of millions of dollars in 
Abbott Laboratories .jpg)
Merck of Germany .gif)
While I don’t advocate postdoctoral positions for individuals unless they plan on doing bench science for the rest of their lives, postdoctoral training is a fact of life for those interested in pursuing academic careers. To that end, The Scientist.com conducts an annual survey that ranks the .jpg)
American competitiveness in engineering, technology and science. Unfortunately, while American competitiveness and innovation in these areas continues to wane, little has been done (except talking) about it! 
As the competition for traditional life sciences jobs continues to intensify, many PhD-trained life scientists are looking for alternate career opportunities. One of the most popular and intriguing options is business—mostly because each of us more than likely knows somebody “who hit it big” by starting a biotechnology or life science-related company. While the entrepreneurial life isn’t for everyone, those intrepid individuals who are willing to give it a shot and possibly be successful ought to be aware of a few basic tools that will make life as an entrepreneur slightly less stressful. To that end, Emma Taylor over at .jpg)
Carl Ichan, the billionaire, activist investor (3).jpg)
Mary Canady author of the Comprendia Blog recently 
(1).jpg)
Amy Bishop, a tenure track faculty member of the Biology Department at the University of Alabama-Huntsville 
In previous 
GlaxoSmithKline (GSK) Britain’s largest pharmaceutical company
.jpg)
I Am Biotech.jpg)
Have you ever found yourself in a situation where you needed important biological, genetic or other life sciences information quickly? Sure, you can Google the topic but it takes time to wade through all of the search results until you find the right one!.jpg)
Politicians, educators and business leaders love to complain about the America’s dwindling competitiveness in math and science and the growing lack of innovation that seems to be pervasive among many American high school and college-aged students. This is the same mantra that I have been hearing for the past 20 years. Unfortunately, while the powers at be like to complain about these things, no government agencies, educational groups or private sector businesses seem to be able to come up with approaches or solutions to these problems (talk about lack of innovation!). .jpg)
Let’s face it; scientists aren’t generally regarded as being funny. While I have met several very funny researchers during my almost 35 year career, the vast majority of my colleagues have been mostly serious and, at times, difficult to amuse; especially when things weren't going so well in the lab.(1).jpg)
Despite .jpg)
While this isn’t a .jpg)
Governor Deval Patrick and the Massachusetts Life Sciences Center .png)
Mark Senak, author of the .jpg)
Mark Senak who writes the EyeonFDA blog has 
.jpg)
In a previous 
Losing a job or getting laid off is without a doubt one of the more emotionally devastating events that most people face. Unfortunately, in these troubling financial times, many more people are likely to face this likelihood than any other time in recent history..jpg)
In today’s edition of the incisive EyeonFDA blog, Mark Senak, provides a .jpg)
I just returned from the 
Over the past year or so, more graduate students and postdoctoral fellows have been asking me about management consulting careers in the life sciences. I spent several years working as an independent management consultant and while it was a great experience the revenue stream was unreliable at best and the ability to work was highly contingent upon the economy. However, I can assure that my experiences as an independent management consultant were marketing different than those of consultants who work at the consulting firms like McKinsey or the Boston Consulting Group. For those of you interested in life style of a high-powered management consultant I highly recommend you visit their websites for more info. 
I received a call today from GDS International, a UK-based b2b publishing company, alerting me to its annual, event called the (1).png)
e-Patients Connections 2009 
Whenever I do resume critiquing at scientific meetings, someone always asks about how to negotiate a job offer. Most of the people that ask the question aren't even close to receiving a job offer and I do my best to deflect the question. However, at a recent meeting, I spent 30 minutes with a PhD student who had received an offer advising him on how to get a better deal from his prospective new employer. This got me thinking and I invited Joe Tringali, a veteran recruiter with lots of negotiating experience to write a blog post about strategies and things to consider when negotiating a job offer..jpg)
An annual survey conducted by Science magazine and the American Association has identified the 
In a previous post I .gif)
NextLevel Pharma 
Have you ever received a call from a “head hunter” who suggests that they might be able to assist you in your job search? Can professional recruiters actually help you find a job? Finally, have you ever wondered what’s in it for the recruiter if they don’t charge jobseekers a fee to help them with their job searches?.jpg)
I previously posted an 
.jpg)
Twitter is arguably the hottest new platform to hit the social media scene is the past five years. Twitter devotees are convinced that anything is possible if the microblogging platform is used correctly. In today’s economy, the most pressing need for many people is finding a job. While Twitter is effective for branding, marketing and occasionally some witty intellectual exchanges, its usefulness for jobseekers has yet to be demonstrated. To that end, there was a recent instructional case study on TwiTip—.gif){kind=icon}
Lisa Roner, blogger and editor for EyeforPharma, recommends a podcast on social media that was created by Dr. Andree Bates, CEO at Eularis, a company that applies analytics to determine the sales impact of specific marketing programs..png)
During my recent trip to Vermont and Woodstock, NY I had several conversations about Twitter. Surprisingly, I was being asked to explain Twitter to my nephews, both of whom are in their early 20s and to family friends who are in their late 40s and beyond. Also, at several recent science career fairs that I attended many graduate students and postdocs had never heard of Twitter or it they had, they don’t use it. Initially, this was puzzling but after considering the most recent Twitterverse demographics –I think the average age of Twitter users is around 35 to 40—it made more sense to me.
Like it or not, writing a carefully-constructed resume or curriculum vitae (as resumes are known in scientific circles) is a vital part of any successful job search. Inexperienced job seekers tend to hastily craft resumes without paying much attention to format, style or content and then wonder why they can’t land job interviews. The best way to approach resume writing is to think of a resume as a work of art–something that requires a lot of thought, creativity and attention to detail. As one well-known professional recruiter and job search expert put it”Trying to find a job without a smart, well-crafted resume is like showing up for dinner at a fancy restaurant in a T-shirt and cutoffs. They won’t let you in.” .jpg)
While many of you may not know this, background checks are routinely run on prospective new employees at most companies and organizatons before job offers are extended. Like it or not background checks are increasingly being run on scientists because of the US anthrax incident that occurred soon after September 11, 2001. I want to emphasize that background checks on being run on ALL employees (not only scientists) before being hired.
Despite dire predictions, the biotechnology industry appears to be weathering the recession better than most. According to a
The “
Back in the late 1990s, applying for jobs online was all the rage! The technology was new and fresh and applying for jobs online was fast and easy. Companies raced to build corporate websites for prospective job applicants, major job boards like Monster and Careerbuilder were launched and human resources professionals though they were ushering in a “new era of employee recruitment and retention.” While applying for jobs online once seemed like a panacea for both job seekers and corporate employers, it never has lived up to all the fanfare and hype!
Despite its humble beginnings in the late 1970s, the biotechnology industry has transformed itself into one of the most vibrant sectors of the American economy. Pharmaceutical companies, once the bell weather of the life sciences industry, have finally conceded that biotechnology and not small molecules are the industry’s future!.jpg)
The economic crisis is having an adverse effect on enrollment at four year colleges and universities. Most four year institutions are reporting record low enrollments. While things are spiraling downward at many four year colleges and universities, business is booming at two year technical schools and community colleges. Seemingly, this ought to be good news for two year institutions. Unfortunately, statewide funding cuts and faculty shortages are making it difficult for community colleges and technical schools to accommodate burgeoning enrollment..jpg)
Over the past few years, a number of search engines designed for the life sciences have appeared. I thought it might be informative for BioJobBlog readers to list some of the more popular ones and how they are used. I want to warn you in advance that this is not a comprehensive list. That said, if I’ve inadvertently omitted your favorite search engine, please feel free contact me or simply list it in the comments section for this post..jpg)
Back in the day—when the economy was sound and jobs were plentiful—an adequately written resume with a sprinkling of keywords and strategically-placed human resources clichés were sufficient to get your foot in the door at most companies. However, in today’s troubled economy where unemployment is rampant, there are certain buzz words and phrases that no longer resonate with hiring managers. According to Liz Ryan, an experienced corporate career advisor who writes for Yahoo Hot Jobs, the following phrases must never appear in a resume if you are a job seeker in today’s market. .jpg)
Amber Johnson at 
While life sciences companies are still reluctant to take the “social media plunge,” many other companies (with active social media programs) frequently hire employees known as social media managers who oversee and run their social networks. This is because successful social media websites require daily attention and are extremely time consuming and labor intensive. In general, employees who are hired for these jobs have strong backgrounds in social media and technology but frequently possess little expertise in the industry that they are working in. Because social media is so new, many hiring managers believe that the social media and technology skills of these managers are more important than an understanding of the industry that they work in. However, while this practice may be acceptable in other industries, it won’t be the case for the social media managers who oversee pharmaceutical, biotechnology and medical devices and diagnostics social media websites. These managers will likely be required to have a firm understanding of current rules and regulations guiding drug development and marketing and advertising of approved life sciences products. This will be necessary if the drug makers who hire these managers want to steer clear of regulatory scrutiny by the US Food and Drug Administration and other regulatory agencies.(1).jpg)
The debate, if you can call it that, over whether or not interactive social media platforms like .jpg)
Mark Sendak, a social media enthusiast and author of the .jpg)
As many of you may know, I attend national science meetings where I offer resume critiquing services and give career development seminars on topics ranging from resume writing to alternate career opportunities for life scientists. Frequently, I critique the resumes of 
After yesterday's post about career planning for life scientists, one of my soon to be former students in the Fundamentals of Bioscience Program aptly pointed out that my readers might have benefitted more if I had, in fact, offered information about alternate career possibilities for bioscientists. I don't want the student to get too overconfident but I had the same thought immediately after I uploaded the post. 
Yesterday, I gave a lecture entitled “Alternate Careers: Taking the Road Less Traveled” to over 100 members of the University of Pennsylvania’s Biomedical Graduate Student Association. As always, there were many good questions and comments during and after the presentation. Some of the career anecdotes offered by several of the students reminded me of a conversation that I had several weeks ago with one of my Fundamentals of Bioscience students—I teach a Product Development and Regulatory Affairs course in the program—who refreshed my memory about a typical graduate student approach to career development and job searching. “We don’t think about jobs or our careers until we begin writing our PhD theses” she said. “Until then, our advisers don’t talk about careers or jobs and only bring it up because our funding will run out” she added. Admittedly, I had forgotten this because so many years have passed since my graduate student days. That said, it forced me to consider how much the life sciences job market has changed since I was graduate student and how vitally important it is for today’s graduate students to think about and possibly explore different career options throughout the course of their graduate training..gif)
Over the past three years, more than
Medtronics, the world's largest medical-device company, 
The Biotechnology Industry Organization (BIO) kicked off its annual meeting in Atlanta, Georgia today and shortly thereafter, issued a 
Over the past several years, I have publicly called for fundamental changes in graduate education and training for life scientists. To that end, I was delighted to read an OP-ED piece in today’s New York Times entitled “End Universities as We Know It” written by Professor Mark C. Taylor, Chairperson of the religion department at Columbia University. .jpg)
While I was at the Experimental Biology meeting in New Orleans, LA this past week I presented a seminar entitled “Using Social Media For Career Development in the Life Sciences.” This was the first time that I presented this talk, and was expecting a large turn out given the popularity of Facebook and more recently Twitter, a microblogging platform. Much to my surprise only 15 students showed up for the talk—many of whom hadn’t heard of Twitter and were only vaguely familiar with Facebook. Luckily, a few attendees had Facebook profiles and one or two were on Twitter so the talk wasn't a complete bust. Nevertheless, the lack of interest in this talk was extremely puzzling to me—my other seminars, “Interviewing Tips” and “Alternate Careers for PhDs” were very well attended and I was booked solid for one-on-one resume critiquing sessions during the five days I was in New Orleans..jpg)
Are you a life sciences or healthcare professional with a passion for computers, IT or software development? If so, you might want to consider a career in health informatics—one of the hottest, new fields in the life sciences and healthcare industries. Health informatics specialists typically have expertise in medical records and claims, clinical care and programming. In other words, they have a foot in two worlds— medicine and technology — and can easily bridge the often daunting gap between them. It is important to point out that there is a difference between healthcare IT and informatics personnel. The health IT people run the servers and install software, but the informatics people are the ones who analyze and interpret clinical/ medical information and work with clinical and other healthcare staff to advise and help them.
Using Facebook and Twitter to find jobs is becoming routine in many industries including healthcare. However, the life sciences industry is lagging behind most others when it comes to social media and recruitment. Nevertheless, many companies and academic institutions are beginning to realize that Facebook (FB), Twitter and other science social networks are good source of qualified candidates for those difficult-to fill job openings. 
As many of you know, the life sciences industry, one of the most highly regulated industries of the economy has been hesitant and reluctant to embrace social media to reach out to patients, physicians and the lay public. This is because the US Food and Drug Administration, specifically Division for Drug Marketing, Advertising and Communications (.jpg)
Facebook contends that it has over 175 million members, making it the largest social network in the world! Interestingly, according to an 
This morning, while doing my usual Twitter review, I came across a tweet from the .jpg)
For the past decade or so, I have worked as a career counselor at national scientific meetings where I present seminars about resume writing, interviewing techniques and other career related issues. About two years ago, I started to hear about the fierce competition for H-1 and J-1 visas that foreign students must obtain to remain in the US to continue their studies and research. Many of the foreign students that I talked with sounded more like immigration lawyers than graduate students or postdocs—I was amazed at how well informed they were about visa availability and the changes and loopholes in US immigration law that can be exploited to obtain visas..jpg)
Over the past ten years or so, pundits have been warning that the US is losing its competitive edge and that it is no longer the world’s leading nation when it comes to innovation in science and technology. Measuring national competitiveness and innovation is very tricky business and until now, most of evidence to support these claims has been anecdotal. According to an .gif)
I have been accumulating anecdotal information about companies,organizations and institutions that use social media tools like Facebook, Twitter YouTube etc. I decided to attempt to conduct an informal survey to determine whether or not the life sciences sector is adopting and embracing social media to meet its objectives (whatever they may be). .jpg)
We recently added a feature to BioCrowd called BioCrunch. Our goal for BioCrunch is to provide Bcrowd members with relevant, interesting and “fresh” content. Vincent and I are big fans of podcasts and PowerPoint presentations! That said, please 
In the February issue of 
Earlier this month, Vincent Racaniello and I launched a new social network called 
Vincent Racaniello
Did you know that the top ten pharmaceutical companies in the world spent close to $50 billion dollars last year on R&D? That sum could be used to purchase the entire US biotechnology industry except for the five largest companies—Genentech, Amgen, Gilead Genzyme and Celgene. Further, pharma’s R&D budget is about 4 times the R&D budget of all of the US biotechnology companies combined. According to a.jpg)
Like it or not, the best way to land a new job whether or not there is a recession is to network. While career counselors and recruiters trumpet the virtues of networking to job seekers, many people really don't understand what it is or how to do it correctly. I found an
For the past five years, I have been giving career development seminars that offer graduate students and postdoctoral fellows alternate careers choices (instead of research) for life scientists. The intent of these seminars is to get students who may not be enamored with a possible life long career at the bench (I know that there a lot of you out there) to think about what they really want to do after they complete their graduate or postdoctoral training..jpg)
The other day I was chatting with .jpg)
I just returned from the 
.jpg)
I became a medical/science writer after a rather circuitous, unconventional and sometimes, checkered career. Along the way, I learned a few things that I thought would be important to share with other PhDs who are seeking to change careers, t broaden their horizons and or simply to bring home a paycheck! I am sure that I missed a few things but here are my top 10 reasons to consider a career in medical/science writing:
The social development of the web 2.0 has largely bypassed science. Hugely popular websites such as Facebook, MySpace, Twitter, Digg, Delicious and the like have millions of members and generate huge amounts of traffic. But those who use these sites come from all walks of life. None are devoted solely to science. 
For the past 60 years, American science was second to none. However, the US is perilously close to losing that distinction. Put simply, American science, like its economy, is in free fall.
According to a survey of 1,800 American professors in the life sciences conducted by economists at the University of Wisconsin-Madison, 90% of life sicentiest hold only one or no patents. This means that remaining 10% hold more than one (and are probably weathier than the other guys). .jpg)
This is the first installment of .jpg)
I came across an interesting article in Forbes Magazine that 